INSERM, U1043, CPTP, CHU purpan, Toulouse, France.
CNRS, U5282 CPTP, CHU purpan, Toulouse, France.
Sci Rep. 2020 May 18;10(1):8177. doi: 10.1038/s41598-020-64847-y.
In the present study we showed that HIV-1 Tat protein stimulated the expression of Indoleamine 2,3 dioxygenase (IDO) -1 in human monocytes derived dendritic cells (MoDC) but not IDO-2 by acting directly at the cell membrane level. This induction of IDO-1 is dependent on the secondary structure of Tat protein, since stimulation with a chemically oxidized Tat protein loses its capacity to induce the production of IDO-1. Among the variety of candidate receptors described for Tat, we demonstrated that Tat protein interacted physically with TLR4/MD2 complex. Strikingly, blockade of Tat-TLR4 interaction by anti-TLR4 antibodies (clone HTA125), LPS-RS, a known TLR4 antagonist, or by soluble recombinant TLR4/MD2 complex inhibited strongly or totally the capacity of Tat to induce IDO-1 in MoDC while such treatments had no effect on IFN-γ-induced IDO-1. Furthermore, we showed that the activation of the transcription factor NF-κB by Tat is essential for the production of IDO-1 by human MoDC. Indeed, Tat activated NF-κB pathway in MoDC as demonstrated by the phosphorylation of p65 in Tat-treated MoDC. Further, we demonstrate that the stimulation of IDO-1 by Tat or by IFN-γ was totally or partially inhibited in the presence of NF-κB inhibitor respectively. These results suggest that Tat and IFN-γ act probably by two distinct mechanisms to induce the production of IDO-1. Our results clearly demonstrated that, although TLR4 pathway is necessary for Tat-induced IDO-1 in MoDC, it seems not to be sufficient since stable transfection of a functional TLR4/MD2 pathway in HEK or HeLa cell lines which are endogenously defectives for TLR4, did not restore the capacity of Tat to induce IDO-1 while IFN-γ treatment induces IDO-1 in HeLa cells independently of TLR4 pathway. These results suggest the involvement of additional stimuli in addition to TLR4 pathway which remain to be identified. Altogether our results demonstrated that, in human MoDC, HIV-1 Tat protein induced IDO-1 expression and activity in a NF-κB dependent-manner by recruiting TLR4 pathway.
在本研究中,我们表明 HIV-1 Tat 蛋白通过直接在细胞膜水平上作用,刺激人单核细胞衍生的树突状细胞(MoDC)中吲哚胺 2,3 双加氧酶(IDO)-1 的表达,但不刺激 IDO-2。这种 IDO-1 的诱导依赖于 Tat 蛋白的二级结构,因为用化学氧化的 Tat 蛋白刺激会失去诱导 IDO-1 产生的能力。在描述的 Tat 的各种候选受体中,我们证明 Tat 蛋白与 TLR4/MD2 复合物物理相互作用。引人注目的是,抗 TLR4 抗体(克隆 HTA125)、LPS-RS(一种已知的 TLR4 拮抗剂)或可溶性重组 TLR4/MD2 复合物阻断 Tat-TLR4 相互作用强烈或完全抑制 Tat 在 MoDC 中诱导 IDO-1 的能力,而这种处理对 IFN-γ 诱导的 IDO-1 没有影响。此外,我们表明,Tat 对转录因子 NF-κB 的激活对于人类 MoDC 中 IDO-1 的产生是必需的。事实上,Tat 通过 MoDC 中 p65 的磷酸化证实了 NF-κB 途径的激活。此外,我们证明,Tat 或 IFN-γ 刺激 IDO-1 的产生分别被 NF-κB 抑制剂完全或部分抑制。这些结果表明,Tat 和 IFN-γ 可能通过两种不同的机制来诱导 IDO-1 的产生。我们的结果清楚地表明,尽管 TLR4 途径对于 Tat 在 MoDC 中诱导 IDO-1 是必要的,但似乎还不够,因为在 HEK 或 HeLa 细胞系中稳定转染功能性 TLR4/MD2 途径,这些细胞系内源性缺乏 TLR4,不能恢复 Tat 诱导 IDO-1 的能力,而 IFN-γ 处理独立于 TLR4 途径诱导 HeLa 细胞中的 IDO-1。这些结果表明,除了 TLR4 途径之外,还涉及到其他刺激物有待确定。总之,我们的结果表明,在人类 MoDC 中,HIV-1 Tat 蛋白通过募集 TLR4 途径,以 NF-κB 依赖的方式诱导 IDO-1 表达和活性。